According to the results of integrated metabolomics and network pharmacology, 6 hub targets, including AKT1, EGFR, ESR1, STAT3, IGF1, and MAPK1, may play significant roles in the effects of EGCG on obesity-related precocious puberty. Here, MAPK1 is linked to obesity disorder.